Fundz

Strella raises $4.25M in Series A extension funding led by SilverBlue to expand fruit ripening technology across the produce supply chain.

PRIVATEOct 23, 2026

Amount Raised

$4.25 Million

Round Type

Series A

Seattle

Investors

PeakbridgeBeta MilouotLeVert VenturesSilverBlue

Description

Seattle-based agricultural technology company Strella has raised $4.25 million in additional Series A funding, bringing its total investment to $26.25 million. The capital will support expansion of the company's IoT-based fruit quality monitoring technology across the fresh produce supply chain. The funding round was led by SilverBlue, with participation from LeVert Ventures, Beta Milouot and PeakBridge. Strella's connected sensors and machine vision technology monitor fruit ripeness and quality to reduce spoilage losses for growers, packers, shippers, distributors and retailers globally.

Who to call at Strella Biotech, and when

A new round usually means Strella Biotech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Strella Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Strella Biotech, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Strella Biotech

Location

Seattle, Washington, United States

About

The USDA’s Economic Research Service estimates roughly 30-40% of US food (80 billion pounds) is wasted every year. Produce is a particularly challenging issue, with 45% of all produce wasted before it ever reaches the consumer. Strella Biotech provides actionable data to optimize the fresh produce supply chain. With proprietary biosensor technology fueled by Internet-of-Things capabilities, Strella offers the produce industry a data-driven approach to ensuring fruit quality throughout every segment of the supply chain, helping to increase margins and reduce shrink by providing dynamic shelf-life predictions. Headquartered in Seattle, Strella is committed to supporting lower carbon emissions from the fresh produce industry and increasing sustainability for a healthier planet. For more information, visit www.strellabiotech.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Strella Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Strella Biotech's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Strella Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.